Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Takahito Endo"'
Autor:
Takaaki Inoue, Fukashi Yamamichi, Takahito Endo, Yasuhiro Kaku, Mikito Horikoshi, Shoji Hara, Masato Fujisawa
Publikováno v:
IJU Case Reports, Vol 2, Iss 5, Pp 245-248 (2019)
Introduction Endoscopic retrograde access to the upper urinary tract after Cohen reimplantation for the treatment of vesicoureteral reflux in children is usually difficult. Case presentation We experienced a case involving a few large ureteral stones
Externí odkaz:
https://doaj.org/article/b35225a9c7bd48abab3780f8ebbcd12a
Autor:
Takahito Endo
Publikováno v:
IJU Case Reports, Vol 5, Iss 5, Pp 418-418 (2022)
Externí odkaz:
https://doaj.org/article/b6bb90cc1f624395be188dfaf8b345be
Autor:
Takahito, Endo, Takeshi, Ishimura, Shun, Nishioka, Naoki, Yokoyama, Satoshi, Ogawa, Masato, Fujisawa
Publikováno v:
Transplantation Proceedings. 54(2):286-292
Background Despite a growing need for everolimus (EVR) to reduce calcineurin inhibitor toxicity in kidney transplantation (KTx), the influence of EVR on the pharmacokinetics of mycophenolic acid (MPA), a mycophenolate mofetil (MMF) active metabolite,
Autor:
Takuya Fujimoto, Yoji Hyodo, Takeshi Ishimura, Yuki Tashiro, Takahito Endo, Shun Nisioka, Naoki Yokoyama, Kazuhiro Yamamoto, Ikuko Yano, Masato Fujisawa
Publikováno v:
Transplantation Proceedings.
Autor:
Fukashi Yamamichi, Yasuhiro Kaku, Shoji Hara, Mikito Horikoshi, Takaaki Inoue, Masato Fujisawa, Takahito Endo
Publikováno v:
IJU Case Reports
IJU Case Reports, Vol 2, Iss 5, Pp 245-248 (2019)
IJU Case Reports, Vol 2, Iss 5, Pp 245-248 (2019)
Introduction Endoscopic retrograde access to the upper urinary tract after Cohen reimplantation for the treatment of vesicoureteral reflux in children is usually difficult. Case presentation We experienced a case involving a few large ureteral stones
Autor:
Naoki Yokoyama, Takeshi Ishimura, Satoshi Ogawa, Teruyuki Oda, Masato Fujisawa, Takahito Endo, Shun Nishioka
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Cardiovascular disease (CVD) is the major cause of death after kidney transplantation (KTx). Everolimus (EVR) is an immunosuppressive agent now widely used in KTx that is...
Autor:
Teruyuki Oda, Masato Fujisawa, Takeshi Ishimura, Satoshi Ogawa, Naoki Yokoyama, Takahito Endo, Shun Nishioka
Publikováno v:
Journal of Urology. 203
Autor:
Naoki Yokoyama, Satoshi Ogawa, Teruyuki Oda, Masato Fujisawa, Takahito Endo, Takeshi Ishimura, Shun Nishioka
Publikováno v:
Journal of Urology. 201
Autor:
Shun Nishioka, Masato Fujisawa, Takahito Endo, Takeshi Ishimura, Satoshi Ogawa, Naoki Yokoyama
Publikováno v:
Annals of Transplantation
BACKGROUND Although renoprotective effects of everolimus (EVR) in kidney transplantation (KTx) have been widely reported, its pathophysiological mechanism remains unclear. MATERIAL AND METHODS We compared changes in eGFR (ΔGFR, ml/min/1.73 m²) and
Autor:
Naoki Yokoyama, Shun Nishioka, Satoshi Ogawa, Masato Fujisawa, Takahito Endo, Takeshi Ishimura, Takuya Fujimoto
Publikováno v:
Korean Journal of Transplantation. 34:S89-S89